Critical Juncture in Hemophilia Treatment: Global Organizations Issue Urgent Call to Action

Critical Juncture in Hemophilia Treatment: Global Organizations Issue Urgent Call to Action
Image

Supported through educational grants from BioMarin, CSL Behring, Pfizer Inc., Roche, and Spark Therapeutics

Essential SSL